Naveen Eipe

Naveen Eipe

Auto-generated profile, based on publicly available information

Naveen Eipe

The Ottawa Hospital

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2016 in BJA Education
Verified
Journal Article
Open access
PDF file
NEN Eipe
N Eipe
SGS Gupta
S Gupta
JPJ Penning
J Penning
Poorly controlled acute pain remains one of the most undesirable consequences after surgery. Despite increased awareness and widespread efforts to address this, reports continue to estimate that a significant number of patients undergoing surgery experience moderate to severe pain, with a majority of them expressing dissatisfaction with their pain management.1 Advances in multimodal analgesia have largely replaced conventional opioid mono-therapy, but continued reliance on opioids to manage postoperative pain may at least partly explain the inadequacy of conventional acute pain management.

1 July 2015 in Pain
Verified
Journal Article
Closed access
NENaveen Eipe
Naveen Eipe
JPJohn Penning
John Penning
FYFatemeh Yazdi
Fatemeh Yazdi
RMRanjeeta Mallick
Ranjeeta Mallick
LTLucy Turner
Lucy Turner
MAMohammed Toseef Ansari
Mohammed Toseef Ansari
Evidence supporting postoperative pain management using pregabalin as an adjunct intervention across various surgical pain models is lacking. The objective of this systematic review was to evaluate "model-specific" comparative effectiveness and harms of pregabalin following a previously published systematic review protocol. MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were searched from inception through August 2013. Data were screened and single extraction with independent verification and dual risk of bias assessment was performed. Quality of evidence (QoE) was rated using the GRADE approach. Primary outcomes were pain relief at rest and on movement and reduction in postoperative analgesic consumption. A total of 1423 records were screened, and 43 studies were included. Perioperative pregabalin resulted in: 16% (95% confidence interval [CI], 9%-21%) reduction in analgesic consumption (moderate QoE, 24 trials) and a small reduction in the magnitude of pain in surgeries associated with pronociceptive pain. Per 1000 patients, 10 more will experience blurred vision (95% CI, 5-20 more; moderate QoE, 17 trials) and 41 more sedation (95% CI, 13-77 more, 17 trials). To prevent 1 case of perioperative nausea and vomiting, the number needed to treat is 11 (95% CI: 7-28, 25 trials). Inadequate evidence addressed outcomes of enhanced recovery and serious harms. Pregabalin analgesic effectiveness is largely restricted to surgical procedures associated with pronociceptive mechanisms. The clinical significance of observed pregabalin benefits must be weighed against the uncertainties about serious harms and enhanced recovery to inform the careful selection of surgical patients. Recommendations for future research are proposed.

1 August 2019 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
AGAkash Goel
Akash Goel
SASaam Azargive
Saam Azargive
JWJoel S. Weissman
Joel S. Weissman
HSHarsha Shanthanna
Harsha Shanthanna
JHJohn G. Hanlon
John G. Hanlon
HCHance Clarke
Hance Clarke

29 June 2019 in Drugs
Verified
Journal Article
Closed access
PDF file
IBImane Belcaid
Imane Belcaid
NENaveen Eipe
Naveen Eipe

1 January 2011 in Pain Research and Management
Verified
Journal Article
Open access
PDF file
NENaveen Eipe
Naveen Eipe
JPJohn Penning
John Penning
Pregabalin is gaining popularity in the perioperative period for its usefulness in treating neuropathic pain and its apparent opioid‐sparing effect. The present report describes the perioperative course of three patients who received pregabalin and experienced significant respiratory depression in the postoperative period. All three patients consented to the report and publication of the present case series. The first patient was elderly with borderline renal dysfunction. She experienced respiratory arrest in the immediate postoperative period following a craniotomy for tumour excision. The second patient presented with severe respiratory depression 12 h after receiving a spinal anesthetic for joint replacement, and was later found to have clinically significant obstructive sleep apnea. The third patient, who was an otherwise healthy elderly individual on benzodiazepines for anxiety, experienced respiratory arrest in the postanesthesia care unit after an uneventful anesthesia for lumbar spine decompression. All of these patients were treated successfully with standard resuscitation measures. Although other causes of respiratory depression in these patients were considered, there appears to be an association between pregabalin and this complication. The present article briefly reviews the evidence regarding the perioperative use of pregabalin. Based on the authors’ experience and the available evidence, they believe that pregabalin may be useful in the management of acute pain in carefully selected patients undergoing certain surgeries. A clinical algorithm has been developed to guide the perioperative use of pregabalin. This algorithm may be helpful in increasing the safety of perioperative pregabalin use.

1 July 2022 in Saudi Journal of Anaesthesia
Verified
Journal Article
Open access
PDF file
NENaveen Eipe
Naveen Eipe
ABAdele S. Budiansky
Adele S. Budiansky
Weight loss (bariatric) surgery is the most commonly performed elective surgical procedure in patients with morbid obesity. In this review, we provide an evidence-based update on perioperative pain management in bariatric anesthesia. We mention some newer preoperative aspects—medical optimization, physical preparation, patient education, and psychosocial factors—that can all improve pain management. In the intraoperative period, with bariatric surgery being almost universally performed laparoscopically, we emphasize the use of non-opioid adjuvant infusions (ketamine, lidocaine, and dexmedetomidine) and suggest some novel regional anesthesia techniques to reduce pain, opioid requirements, and side effects. We discuss some postoperative strategies that additionally focus on patient safety and identify patients at risk of persistent pain and opioid use after bariatric surgery. This review suggests that the use of a structured, step-wise, severity-based, opioid-sparing multimodal analgesic protocol within an enhanced recovery after surgery (ERAS) framework can improve postoperative pain management. Overall, by incorporating all these aspects throughout the perioperative journey ensures improved patient safety and outcomes from pain management in bariatric anesthesia.